Investigación / Grupos de investigación

Grupo  3

Enfermedades Sistémicas de Base Autoinmune

Publicaciones (396)

  • Narvaez, J; Borrell, H; Sanchez-Alonso, F; Rua-Figueroa, I; Lopez-Longo, FJ; Galindo-Izquierdo, M; Calvo-Alen, J; Fernandez-Nebro, A; Olive, A; Andreu, JL; Martinez-Taboada, V; Nolla, JM; Pego-Reigosa, JM.

    Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort

    ARTHRITIS RESEARCH & THERAPY. 2018; 20: 280-280 Nº de citas: 49 [doi:10.1186/s13075-018-1776-8]

  • Naredo, E; Rutigliano, IM; Janta, I; Scirocco, C; Valor, L; Figus, F; Carreno, L; Garrido, J; Iagnocco, A.

    Agreement between semiquantitative and quantitative Doppler scoring systems for the assessment of synovial pathological vascularisation in rheumatoid arthritis

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2018; 36(6): 970-975

  • Gonzalez, C; Rodriguez, RC; Torre-Alonso, JC; Collantes, E; Castaneda, S; Hernandez, MV; Urruticoechea-Arana, A; Nieto-Gonzalez, JC; Garcia, J; Abad, MA; Ramirez, J; Suarez, C; Dalmau, R; Martin-Arranz, MD; Leon, L; Hermosa, JC; Obaya, JC; Oton, T; Carmona, L.

    Recommendations for the Management of Comorbidity in Patients With Axial Spondyloarthritis in Clinical Practice

    Reumatologia Clinica. 2018; 14(6): 346-359 Nº de citas: 5 [doi:10.1016/j.reuma.2017.03.011]

  • Rodriguez-Jimenez, P; Mir-Viladrich, I; Chicharro, P; Solano-Lopez, G; Lopez-Longo, FJ; Taxonera, C; Sanchez-Martinez, P; Martinez-Lacasa, X; Garcia-Gasalla, M; Dorca, J; Arias-Guillen, M; Garcia-Garcia, JM; Dauden, E.

    Prevention and treatment of tubercutosis infection in candidates for biologic

    Actas Dermo-Sifiliograficas. 2018; 109(7): 584-601 Nº de citas: 8 [doi:10.1016/j.ad.2018.03.013]

  • Cea-Calvo, L; Raya, E; Marras, C; Salman-Monte, TC; Ortiz, A; Salvador, G; Monteagudo, I; Carmona, L; Fernandez, S; Arteaga, MJ; Calvo-Allen, J.

    The beliefs of rheumatoid arthritis patients in their subcutaneous biological drug: strengths and areas of concern

    RHEUMATOLOGY INTERNATIONAL. 2018; 38(9): 1735-1740 Nº de citas: 6 [doi:10.1007/s00296-018-4097-y]

  • Martin-Varillas, JL; Calvo-Rio, V; Beltran, E; Sanchez-Burson, J; Mesquida, M; Adan, A; Hernandez, MV; Garfella, MH; Pascual, EV; Martinez-Costa, L; Sellas-Fernandez, A; Cordero-Coma, M; Diaz-Llopis, M; Gallego, R; Salom, D; Ortego, N; Garcia-Serrano, JL; Callejas-Rubio, JL; Herreras, JM; Garcia-Aparicio, A; Maiz, O; Blanco, A; Torre, I; Diaz-Valle, D; Pato, E; Aurrecoechea, E; Caracuel, MA; Gamero, F; Minguez, E; Carrasco-Cubero, C; Olive, A; Vazquez, J; Ruiz-Moreno, O; Manero, J; Munoz-Fernandez, S; Martinez, MG; Rubio-Romero, E; de Miera, FJTS; Longo, FJL; Nolla, JM; Revenga, M; Gonzalez-Vela, C; Loricera, J; Atienza-Mateo, B; Demetrio-Pablo, R; Hernandez, JL; Gonzalez-Gay, MA; Blanco, R.

    Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behcet's Disease

    OPHTHALMOLOGY. 2018; 125(9): 1444-1451 Nº de citas: 73 [doi:10.1016/j.ophtha.2018.02.020]

  • Ramirez, J; Nieto-Gonzalez, JC; Rodriguez, RC; Castaneda, S; Carmona, L.

    Prevalence and risk factors for osteoporosis and fractures in axial spondyloarthritis: A systematic review and meta-analysis

    SEMINARS IN ARTHRITIS AND RHEUMATISM. 2018; 48(1): 44-52 Nº de citas: 50 [doi:10.1016/j.semarthrit.2017.12.001]

  • Valor, L; Garrido, J; Martinez-Estupinan, L; Hernandez-Florez, D; Janta, I; Lopez-Longo, FJ; Monteagudo, I; Gonzalez, CM; Naredo, E.

    Identifying markers of sustained remission in rheumatoid arthritis patients on long-term tapered biological disease-modifying antirheumatic drugs

    RHEUMATOLOGY INTERNATIONAL. 2018; 38(8): 1465-1470 Nº de citas: 7 [doi:10.1007/s00296-018-4087-0]

  • Julia, A; Lopez-Longo, FJ; Venegas, JJP; Bonas-Guarch, S; Olive, A; Andreu, JL; Aguirre-Zamorano, MA; Vela, P; Nolla, JM; de la Fuente, JLM; Zea, A; Pego-Reigosa, JM; Freire, M; Diez, E; Rodriguez-Almaraz, E; Carreira, P; Blanco, R; Taboada, VM; Lopez-Lasanta, M; Corbeto, ML; Mercader, JM; Torrents, D; Absher, D; Marsal, S; Fernandez-Nebro, A.

    Genome-wide association study meta-analysis identifies five new loci for systemic lupus erythematosus

    ARTHRITIS RESEARCH & THERAPY. 2018; 20: 100-100 Nº de citas: 86 [doi:10.1186/s13075-018-1604-1]

  • Gonzalez-Serna, D; Ortiz-Fernandez, L; Vargas, S; Garcia, A; Raya, E; Fernandez-Gutierrez, B; Lopez-Longo, FJ; Balsa, A; Gonzalez-Alvaro, I; Narvaez, J; Gomez-Vaquero, C; Sabio, JM; Garcia-Portales, R; Gonzalez-Escribano, MF; Tolosa, C; Carreira, P; Kiemeney, L; Coenen, MJH; Witte, T; Schneider, M; Gonzalez-Gay, MA; Martin, J.

    Association of a rare variant of the TNFSF13B gene with susceptibility to Rheumatoid Arthritis and Systemic Lupus Erythematosus

    Scientific Reports. 2018; 8: 8195-8195 Nº de citas: 18 [doi:10.1038/s41598-018-26573-4]

  • Lopez-Rodriguez, R; Perez-Pampin, E; Marquez, A; Blanco, FJ; Joven, B; Carreira, P; Ferrer, MA; Caliz, R; Valor, L; Narvaez, J; Canete, JD; Ordonez, MD; Manrique-Arija, S; Vasilopoulos, Y; Balsa, A; Pascual-Salcedo, D; Moreno-Ramos, MJ; Alegre-Sancho, JJ; Navarro-Sarabia, F; Moreira, V; Garcia-Portales, R; Raya, E; Magro-Checa, C; Martin, J; Gomez-Reino, JJ; Gonzalez, A.

    Validation study of genetic biomarkers of response to TNF inhibitors in rheumatoid arthritis

    PLoS One. 2018; 13(5): Nº de citas: 15 [doi:10.1371/journal.pone.0196793]

  • Collado, P; Windschall, D; Vojinovic, J; Magni-Manzoni, S; Balint, P; Bruyn, GAW; Hernandez-Diaz, C; Nieto, JC; Ravagnani, V; Tzaribachev, N; Iagnocco, A; D'Agostino, MA; Naredo, E; OMERACT Ultrasound Subtask Force.

    Amendment of the OMERACT ultrasound definitions of joints' features in healthy children when using the DOPPLER technique

    Pediatric Rheumatology. 2018; 16: 23-23 Nº de citas: 48 [doi:10.1186/s12969-018-0240-2]

  • Lopez-Longo, FJ; Seoane-Mato, D; Martin-Martinez, MA; Sanchez-Alonso, F; emAR II Grp.

    Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis

    RHEUMATOLOGY INTERNATIONAL. 2018; 38(4): 589-598 Nº de citas: 7 [doi:10.1007/s00296-018-3933-4]

  • Ammitzboll-Danielsen, M; Ostergaard, M; Naredo, E; Iagnocco, A; Moller, I; D'Agostino, MA; Gandjbakhch, F; Terslev, L.

    The Use of the OMERACT Ultrasound Tenosynovitis Scoring System in Multicenter Clinical Trials

    JOURNAL OF RHEUMATOLOGY. 2018; 45(2): 165-169 Nº de citas: 7 [doi:10.3899/jrheum.170501]

  • Martinez-Barrio, J; Valor, L; Lopez-Longo, FJ.

    Facts and controversies in mixed connective tissue disease

    MEDICINA CLINICA. 2018; 150(1): 26-32 Nº de citas: 12 [doi:10.1016/j.medcli.2017.06.066]

  • Villota, O; Diaz, M; Ceron, C; Moller, I; Naredo, E; Saaibi, DL.

    From a Formal Training Program in Musculoskeletal Ultrasound (MSUS) to a High Reproducibility for MSUS Ultrasound in Rheumatoid Arthritis

    Current Rheumatology Reviews. 2018; 14(3): 264-270 Nº de citas: 4 [doi:10.2174/1573397113666170728125557]

  • del Pino, MD; Andres, A; Bernabeu, AA; de Juan-Rivera, J; Fernandez, E; Diaz, JDG; Hernandez, D; Luno, J; Fernandez, IM; Paniagua, J; de la Pazk, MP; Rodriguez-Perez, JC; Santamaria, R; Torra, R; Ambros, JT; Vidau, P; Torregrosa, JV.

    Fabry Nephropathy: An Evidence-Based Narrative Review

    KIDNEY & BLOOD PRESSURE RESEARCH. 2018; 43(2): 406-421 Nº de citas: 36 [doi:10.1159/000488121]

  • Martinez-Estupinan, L; Hernandez-Florez, D; Janta, I; Ovalles-Bonilla, JG; Nieto, JC; Gonzalez-Fernandez, CM; del Rio, T; Monteagudo, I; Lopez-Longo, FJ; Naredo, E; Valor, L.

    An exploratory study to determine whether infliximab modifies levels of rheumatoid factor and antibodies to cyclic citrullinated peptides in rheumatoid arthritis patients

    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. 2018; 36(1): 88-93 Nº de citas: 1